Genome Integration vs Plasmid Expression

Genome Integration vs Plasmid Expression describes the fundamental choice in genetic engineering between inserting a transgene directly into the host chromosome or maintaining it on an extrachromosomal plasmid vector ¹.

How It Works

Plasmid-based expression offers rapid prototyping, high gene dosage through multi-copy plasmids, and easy construct iteration. However, plasmids impose a metabolic burden, require continuous antibiotic selection for maintenance, and can be lost from the population over generations (segregational instability). Copy number variation between cells also introduces expression heterogeneity.

Genomic integration provides stable, selection-free maintenance of the transgene as part of the chromosome. Integrated constructs are replicated faithfully during cell division and produce more uniform expression across the population. The trade-off is typically lower expression levels (single or few copies) and more laborious construction workflows.

The choice depends on the application. Early-stage pathway prototyping benefits from plasmid flexibility. Production strains for industrial fermentation favor integration for long-term stability without antibiotics. Therapeutic applications almost universally require integration to avoid plasmid loss and to satisfy regulatory requirements for genetic stability ¹.

Computational Considerations

Kinetic models simulate expression output as a function of copy number, promoter strength, and metabolic burden. Population dynamics models predict plasmid retention rates under different growth conditions and selection regimes, helping engineers decide when to transition from plasmid-based prototyping to chromosomal integration ².

---

Woolf Software builds computational tools for genome editing design and off-target prediction. Get in touch.